Long-term protective efficacy with a BCG-prime ID93/GLA-SE boost regimen against the hyper-virulent Mycobacterium tuberculosis strain K in a mouse model

Since ID93/GLA-SE was developed as a targeted BCG-prime booster vaccine, in the present study, we evaluated the protective efficacy of ID93/GLA-SE as a boost to a BCG-prime against the hypervirulent Mycobacterium tuberculosis (Mtb) K challenge to provide further information on the development and ap...

Descripción completa

Detalles Bibliográficos
Autores principales: Kwon, Kee Woong, Lee, Ara, Larsen, Sasha E., Baldwin, Susan L., Coler, Rhea N., Reed, Steven G., Cho, Sang-Nae, Ha, Sang-Jun, Shin, Sung Jae
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6820558/
https://www.ncbi.nlm.nih.gov/pubmed/31664157
http://dx.doi.org/10.1038/s41598-019-52146-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6820558/
https://www.ncbi.nlm.nih.gov/pubmed/31664157
http://dx.doi.org/10.1038/s41598-019-52146-0

Ejemplares similares